{"schema_version":"secwatch.filing_event.v1","accession":"0001501697-25-000008","form_type":"8-K","ticker":"XFOR","cik":"0001501697","company_name":"X4 Pharmaceuticals, Inc","filed_at":"2025-08-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.143036+00:00","generated_at":"2026-05-17T10:12:40.315848+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"X4 Pharmaceuticals board members McGirr and Woods resign; audit committee reconstituted","bullets":["David McGirr and R. Keith Woods resigned from the board effective August 22, 2025, with no disagreement.","Michael Wyzga appointed as chair of the audit committee.","Francoise de Craecker and Gary Bridger appointed as members of the audit committee.","Resignations cover all committees; departure not related to operations, policies, or practices."],"urls":{"canonical":"https://secwatch.observer/filing/0001501697-25-000008","json":"https://secwatch.observer/filing/0001501697-25-000008.json","markdown":"https://secwatch.observer/filing/0001501697-25-000008.md","text":"https://secwatch.observer/filing/0001501697-25-000008.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1501697/000150169725000008/0001501697-25-000008-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1501697/000150169725000008/xfor-20250822.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T10:12:40.315848+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}